Gene · 6853
Papers3,694
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,694
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SCD Inhibition Protects from α-Synuclein-Induced Neurotoxicity But Is Toxic to Early Neuron Cultures. | eNeuro | 2021 | 34301719 | PubTator, text mining | PubMed |
| COVID-19 in Children: Expressions of Type I/II/III Interferons, TRIM28, SETDB1, and Endogenous Retroviruses in Mild and Severe Cases. | Int J Mol Sci | 2021 | 34299101 | PubTator, text mining | PubMed |
| Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology. | Stem Cell Reports | 2021 | 34297942 | PubTator, text mining | PubMed |
| Bioluminescent Optogenetics: A Novel Experimental Therapy to Promote Axon Regeneration after Peripheral Nerve Injury. | Int J Mol Sci | 2021 | 34281270 | PubTator, text mining | PubMed |
| Blockage of Drp1 phosphorylation at Ser579 protects neurons against Aβ1‑42‑induced degeneration. | Mol Med Rep | 2021 | 34278489 | PubTator, text mining | PubMed |
| Clinical Characteristics and Genetic Etiology of Children With Developmental Language Disorder. | Front Pediatr | 2021 | 34277514 | PubTator, text mining | PubMed |
| Astrocytes-derived extracellular vesicles in motion at the neuron surface: Involvement of the prion protein. | J Extracell Vesicles | 2021 | 34276899 | PubTator, text mining | PubMed |
| Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK. | PLoS One | 2021 | 34264955 | PubTator, text mining | PubMed |
| Gene-Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres. | Environ Health Perspect | 2021 | 34259569 | PubTator, text mining | PubMed |
| Familial SYN1 variants related neurodevelopmental disorders in Asian pediatric patients. | BMC Med Genomics | 2021 | 34243774 | PubTator, text mining | PubMed |
| PIAS2-mediated blockade of IFN-β signaling: a basis for sporadic Parkinson disease dementia. | Mol Psychiatry | 2021 | 34234281 | PubTator, text mining | PubMed |
| Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins. | Orphanet J Rare Dis | 2021 | 34229750 | PubTator, text mining | PubMed |
| Infectious disease-associated encephalopathies. | Crit Care | 2021 | 34229735 | PubTator, text mining | PubMed |
| Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson's Disease: Current Understanding and Knowledge Gaps. | Aging Dis | 2021 | 34221553 | PubTator, text mining | PubMed |
| ATR regulates neuronal activity by modulating presynaptic firing. | Nat Commun | 2021 | 34210973 | PubTator, text mining | PubMed |
| Current Approaches and Tools Used in Drug Development against Parkinson's Disease. | Biomolecules | 2021 | 34208760 | PubTator, text mining | PubMed |
| Activation of 6-8-week-old new mature adult-born dentate granule cells contributes to anxiety-like behavior. | Neurobiol Stress | 2021 | 34195305 | PubTator, text mining | PubMed |
| Identification of key miRNAs and their targets in peripheral blood mononuclear cells of IgA nephropathy using bioinformatics analysis. | Medicine (Baltimore) | 2021 | 34190177 | PubTator, text mining | PubMed |
| Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors. | NPJ Parkinsons Dis | 2021 | 34183676 | PubTator, text mining | PubMed |
| Thymosin β4 reverses phenotypic polarization of glial cells and cognitive impairment via negative regulation of NF-κB signaling axis in APP/PS1 mice. | J Neuroinflammation | 2021 | 34183019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6853/papers?page=56